Clinical Trial Update: A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety and efficacy of Thymosin Beta-4 for corneal wound healing in diabetes; the trial was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Thymosin beta-4 (thymosin beta-4)

Snippet

Sponsor: ReGenTree, LLC | Conditions: Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2010-04-13